pIgR: frenemy of inflammation, EMT, and HCC progression.
作者信息
Sphyris Nathalie, Mani Sendurai A
出版信息
J Natl Cancer Inst. 2011 Nov 16;103(22):1644-5. doi: 10.1093/jnci/djr421. Epub 2011 Oct 24.
Abstract
摘要
相似文献
1
pIgR: frenemy of inflammation, EMT, and HCC progression.
J Natl Cancer Inst. 2011 Nov 16;103(22):1644-5. doi: 10.1093/jnci/djr421. Epub 2011 Oct 24.
2
The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma.
J Natl Cancer Inst. 2011 Nov 16;103(22):1696-712. doi: 10.1093/jnci/djr360. Epub 2011 Oct 24.
3
Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.
Hepatology. 2017 Jun;65(6):1948-1962. doi: 10.1002/hep.29036. Epub 2017 Apr 28.
4
HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
Exp Cell Res. 2019 Aug 1;381(1):66-76. doi: 10.1016/j.yexcr.2019.04.030. Epub 2019 Apr 30.
5
Polymeric immunoglobulin receptor (PIGR) exerts oncogenic functions via activating ribosome pathway in hepatocellular carcinoma.
Int J Med Sci. 2021 Jan 1;18(2):364-371. doi: 10.7150/ijms.49790. eCollection 2021.
6
Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Hepatology. 2013 Feb;57(2):610-24. doi: 10.1002/hep.26029.
7
Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Oncotarget. 2016 Jul 12;7(28):43588-43603. doi: 10.18632/oncotarget.9635.
8
Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Ann Surg Oncol. 2012 May;19(5):1700-6. doi: 10.1245/s10434-011-1772-6. Epub 2011 May 17.
9
SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.
J Cell Mol Med. 2020 Sep;24(18):10714-10729. doi: 10.1111/jcmm.15693. Epub 2020 Aug 3.
10
Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
J Hepatol. 2022 Apr;76(4):883-895. doi: 10.1016/j.jhep.2021.12.005. Epub 2021 Dec 16.
引用本文的文献
1
Multi-modal analyses of proteomic measurements associated with type 2 diabetes from the Project Baseline Health Study.
Commun Med (Lond). 2025 Jul 3;5(1):272. doi: 10.1038/s43856-025-00964-x.
2
PIGR predicts good clinical outcomes and plays a tumor suppressor role in the development of breast cancer.
Front Oncol. 2025 May 2;15:1439120. doi: 10.3389/fonc.2025.1439120. eCollection 2025.
3
Spatial transcriptomics delineates potential differences in intestinal phenotypes of cardiac and classical necrotizing enterocolitis.
iScience. 2025 Mar 7;28(4):112166. doi: 10.1016/j.isci.2025.112166. eCollection 2025 Apr 18.
4
Single-cell RNA sequencing reveals the immune microenvironment and signaling networks in cystitis glandularis.
Front Immunol. 2023 Feb 6;14:1083598. doi: 10.3389/fimmu.2023.1083598. eCollection 2023.
5
EMT and Inflammation: Crossroads in HCC.
J Gastrointest Cancer. 2023 Mar;54(1):204-212. doi: 10.1007/s12029-021-00801-z. Epub 2022 Jan 12.
6
A Bioinformatic Analysis of Correlations between Polymeric Immunoglobulin Receptor (PIGR) and Liver Fibrosis Progression.
Biomed Res Int. 2021 Apr 10;2021:5541780. doi: 10.1155/2021/5541780. eCollection 2021.
7
Polymeric immunoglobulin receptor (PIGR) exerts oncogenic functions via activating ribosome pathway in hepatocellular carcinoma.
Int J Med Sci. 2021 Jan 1;18(2):364-371. doi: 10.7150/ijms.49790. eCollection 2021.
8
CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling.
Aging (Albany NY). 2018 Oct 11;10(10):2570-2584. doi: 10.18632/aging.101571.
9
MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial-mensenchymal transition.
FEBS Open Bio. 2015 Nov 10;5:900-7. doi: 10.1016/j.fob.2015.11.001. eCollection 2015.
10
Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients.
J Cancer. 2015 Mar 26;6(5):477-81. doi: 10.7150/jca.11715. eCollection 2015.
本文引用的文献
1
The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma.
J Natl Cancer Inst. 2011 Nov 16;103(22):1696-712. doi: 10.1093/jnci/djr360. Epub 2011 Oct 24.
2
Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S539-48. doi: 10.1245/s10434-011-2040-5. Epub 2011 Aug 31.
3
Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
J Hepatol. 2012 Jan;56(1):267-75. doi: 10.1016/j.jhep.2011.07.007. Epub 2011 Jul 23.
4
Polymeric immunoglobulin receptor.
J Oral Sci. 2011 Jun;53(2):147-56. doi: 10.2334/josnusd.53.147.
5
Non-Smad signaling pathways.
Cell Tissue Res. 2012 Jan;347(1):11-20. doi: 10.1007/s00441-011-1201-y. Epub 2011 Jun 24.
6
Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?
Cancer Res. 2011 May 15;71(10):3701-8. doi: 10.1158/0008-5472.CAN-10-3951. Epub 2011 Apr 4.
7
Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.
J Hepatol. 2011 Oct;55(4):838-45. doi: 10.1016/j.jhep.2010.12.043. Epub 2011 Feb 18.
8
The dynamic roles of TGF-β in cancer.
J Pathol. 2011 Jan;223(2):205-18. doi: 10.1002/path.2785. Epub 2010 Oct 18.
9
Transforming growth factor-beta: recent advances on its role in immune tolerance.
Methods Mol Biol. 2011;677:303-38. doi: 10.1007/978-1-60761-869-0_21.
10
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.
Oncogene. 2010 Aug 26;29(34):4741-51. doi: 10.1038/onc.2010.215. Epub 2010 Jun 7.
Zotero 插件